100 related articles for article (PubMed ID: 2114820)
1. Cytokine stimulation of antibody-dependent cellular cytotoxicity (ADCC) enhances cytolytic but not binding capacity of peritoneal macrophages.
Fehr HG; Fan S; Lötzerich H; Appell HJ
Anticancer Res; 1990; 10(3):821-5. PubMed ID: 2114820
[TBL] [Abstract][Full Text] [Related]
2. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
Ding AH; Nathan CF; Stuehr DJ
J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757
[TBL] [Abstract][Full Text] [Related]
3. Activation of macrophages for ADCC in vitro: effects of IL-4, TNF, interferons-alpha/beta, interferon-gamma, and GM-CSF.
Fan S; Fehr HG; Adams D
Cell Immunol; 1991 Jun; 135(1):78-87. PubMed ID: 1708310
[TBL] [Abstract][Full Text] [Related]
4. The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha.
Eisenthal A; Rosenberg SA
J Immunol; 1989 Apr; 142(7):2307-13. PubMed ID: 2647849
[TBL] [Abstract][Full Text] [Related]
5. Combinations of the cytokines IL-12, IL-2 and IFN-alpha significantly augment whereas the cytokine IL-4 suppresses the cytokine-induced antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2.
Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf I
Cytokine; 2000 Jun; 12(6):756-61. PubMed ID: 10843759
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
Chen L; Suzuki Y; Wheelock EF
J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
8. The ADCC capacity of macrophages from C3H/HeJ and A/J mice can be augmented by BCG.
Koren HS; Meltzer MS; Adams DO
J Immunol; 1981 Mar; 126(3):1013-5. PubMed ID: 7007498
[TBL] [Abstract][Full Text] [Related]
9. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
Sato K; Tomioka H; Saito H
Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
[TBL] [Abstract][Full Text] [Related]
10. Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity.
Ding AH; Nathan CF
J Immunol; 1987 Sep; 139(6):1971-7. PubMed ID: 3040860
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester-stimulated superoxide production by murine bone marrow-derived macrophages requires preexposure to cytokines.
Phillips WA; Hamilton JA
J Immunol; 1989 Apr; 142(7):2445-9. PubMed ID: 2538510
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
Bermudez LE; Young LS
J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
[TBL] [Abstract][Full Text] [Related]
13. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction.
Xing Z; Zganiacz A; Santosuosso M
J Leukoc Biol; 2000 Dec; 68(6):897-902. PubMed ID: 11129658
[TBL] [Abstract][Full Text] [Related]
14. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
15. Role of cytokines and nitric oxide in the induction of tuberculostatic macrophage functions.
Petricevich VL; Alves RC
Mediators Inflamm; 2000; 9(6):261-9. PubMed ID: 11213909
[TBL] [Abstract][Full Text] [Related]
16. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
17. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
Pak AS; Ip G; Wright MA; Young MR
Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
[TBL] [Abstract][Full Text] [Related]
18. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
Munn DH; Armstrong E
Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
[TBL] [Abstract][Full Text] [Related]
19. Influence of acetylsalicylic acid on antibody-dependent cellular cytotoxicity (ADCC) of peritoneal macrophages.
Lötzerich H; Jäpel M; Rogalla K
Anticancer Res; 1993; 13(1):87-91. PubMed ID: 8476231
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of selective tumor cell binding by activated murine macrophages in response to phorbol myristate acetate.
Somers SD; Adams DO
J Immunol; 1986 Mar; 136(6):2323-32. PubMed ID: 3512713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]